Clinical Trial Update: System-level Monitoring of Immune Activation Concerning Susceptibility to Sepsis in Trauma Patients

View source ↗

Summary

The clinical trial NCT01472952 investigating system-level immune activation and susceptibility to sepsis in trauma patients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Universitätsmedizin Mannheim | Conditions: Trauma, Sepsis | Status: WITHDRAWN